We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Mereo Biopharma Group Plc | LSE:MPH | London | Ordinary Share | GB00BZ4G2K23 | ORD GBP0.003 (REG S) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 26.50 | 26.00 | 27.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
17/4/2020 08:15 | Interesting. | someuwin | |
17/4/2020 07:14 | Quite happy for any poster here to share information I've posted on other chat sites as I only use ADVFN. :-) | showmethemoneyhoney01 | |
17/4/2020 06:23 | Any serious interest from a large Pharma and this will go for well over £1 imo. It is grossly undervalued with the projects they have at advanced levels. Shares go up and down with low volume as so many shares are not held in public hands. Some analyst has given a £6.50 12 month on the stock which gives an idea on potential future value. Link below:- | showmethemoneyhoney01 | |
17/4/2020 06:20 | Interesting article from Jan 2020 on institutions owning MPH. Small extract below What Does The Institutional Ownership Tell Us About Mereo BioPharma Group? Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices. Mereo BioPharma Group already has institutions on the share registry. Indeed, they own 60% of the company. This implies the analysts working for those institutions have looked at the stock and they like it. But just like anyone else, they could be wrong. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Mereo BioPharma Group, (below). Of course, keep in mind that there are other factors to consider, too. | showmethemoneyhoney01 | |
16/4/2020 23:34 | Onwards & upwards, 100p + later in Q4 | ny boy | |
16/4/2020 23:11 | I agree which is why I built up a reasonable holding after seeing the advanced stages the company are at with a couple of projects a few months ago on the last spike. I topped up today after seeing the interest on the Nasdaq pre trading this morning. Should be an exciting few days as the volumes in the US indicate something has leaked. There is quite a large institutional holding which is unusual for a small cap company. I don't think they would agree to any sale unless it was at a huge premium to current market cap. | showmethemoneyhoney01 | |
16/4/2020 23:06 | Pocket money for a big Pharma to buy us as we are way undervalued at the moment. | leedslad001 | |
16/4/2020 23:05 | Bumpa 33. Second that! Companies that want to buy their way into the TIGIT field have a few options, including Arcus. Other companies with anti-TIGIT drugs in their pipelines include iTeos Therapeutics and Mereo BioPharma. Shares in Mereo rose 25% in early trading in London following the report of Gilead’s interest in Arcus. And iTeos is a privately held company that raised $125 million at the start of the month | showmethemoneyhoney01 | |
16/4/2020 22:59 | Leedslad. Not only that but over $1m dollars in trades. For a £31m market cap company where most shares are not in public hands, very interesting development that not only the price held, but the huge relative volume involved. | showmethemoneyhoney01 | |
16/4/2020 21:53 | Closed 1.50 in US | leedslad001 | |
16/4/2020 17:22 | Take it Zak has finished topping up? | oapknob1 | |
16/4/2020 16:55 | 60p, that would be nice for starters :-) | showmethemoneyhoney01 | |
16/4/2020 16:35 | Another Biopharma ready for take off?......."valued at £1.10 in the US, currently 31% up on the day over there (up over 40% pre-open). Zak Mir gives an upward target of 60p here" | master rsi | |
16/4/2020 16:28 | Has broken the last 30 minutes the range trend as is now gone to $1.50 | master rsi | |
16/4/2020 16:16 | The volume was really high at the start on the Nasdaq the range for the last 30 minutes has been $1.35 to 1.45 | master rsi | |
16/4/2020 15:37 | Over 500,000 shares traded in US. That's about $700,000 in just over an hour. Something is afoot with that volume. | showmethemoneyhoney01 | |
16/4/2020 15:35 | On any good rise, there is always the one who bought earlier and takes profits | master rsi | |
16/4/2020 15:29 | Very strange... You'd think this would gap up at some point... Must be a UK seller not in the USA. | babbler | |
16/4/2020 15:15 | showmethemoneyhoney0 The volume is allways very important, meaning there is interest in the shares at that special time and makes the share price move, usually prelude to some news. Now it could easily be a two ways trading, just like over here. It seems over there are doing much the same as over here, marked up and then spike down, every so often. Share Volume 372,814 50 Day Average Vol. 96,698 | master rsi | |
16/4/2020 15:01 | Master RSI, what do you make of the volume. 3 times traded in 30 mins than they average in daily volume? | showmethemoneyhoney01 | |
16/4/2020 14:58 | though there was that spike to 1.75, I like the intraday trend ladder shape | master rsi | |
16/4/2020 14:57 | Here's the link. Volume is crazy $278k in under 30 mins | showmethemoneyhoney01 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions